eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2021
vol. 72
 
Share:
Share:
more
 
 
abstract:
Short report

Endomyocardial biopsy: a 21st century diagnostic tool

Rosa A.M.H. Gouveia
1, 2, 3
,
Maria João Andrade
4
,
Carlos Aguiar
4
,
Sância Ramos
3

1.
Pathology and Histology, Faculty of Life Sciences, University of Madeira, Portugal
2.
Clinical and Anatomical Pathology Laboratory (LANA), Funchal, Madeira, Portugal
3.
Pathology, Hospital de Santa Cruz – CHLO, Lisboa, Portugal
4.
Cardiology, Hospital de Santa Cruz – CHLO, Lisboa, Portugal
Pol J Pathol 2021; 73 (4): 356-357
Online publish date: 2022/03/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The question of the utility of Endomyocardial Biopsy (EMB) often and recurrently raises.

It is claimed that the image techniques provide identical results without the risks of an invasive procedure. It is a fact that the impressive technico-scientific development of cardiovascular imagological methodologies covers a broad spectrum of diagnosis. It is also a fact that endomyocardial biopsy is not completely risk-free. Yet, when performed by experienced professionals in reference centres, endomyocardial biopsies my disclose a final unexpected nosologic entity, confirm or exclude a proposed diagnosis and, even when not showing specific lesions in the examined samples, EMB may point to a multifocal involvement of the heart that eventually skipped the fragments collected [1, 2, 3].
keywords:

endomyocardial biopsy, native heart, cardiac graft, 21st century

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.